Events Schedule » Modular Targeted Molecular Imaging Agents to Better Detect Cancer

The overall goal of our research project is to create targeted molecular imaging agents (TMIAs) for early detection and accurate diagnosis of cancer. In our group peptides are constructed containing imaging groups for near infrared fluorescence (NIR), photoacoustic (PA), magnetic resonance imaging (MRI) and positron emission tomography (PET).  A targeting group is conjugated in the last step to make the imaging agents selective for cancer tissue.  By use of a modular method multi-modal agents are available for targeted NIR-NMR imaging, for example.  One of our methods of evaluation is confocal fluorescence microscopy (CFM) in which cancer cells can be shown to specifically “light up” with our TMIAs.    Hans Schmitthenner

« Go back to events
Date
Saturday, October 18
Time
12:30 pm - 1:30 pm
View More Info

The overall goal of our research project is to create targeted molecular imaging agents (TMIAs) for early detection and accurate diagnosis of cancer. In our group peptides are constructed containing imaging groups for near infrared fluorescence (NIR), photoacoustic (PA), magnetic resonance imaging (MRI) and positron emission tomography (PET).  A targeting group is conjugated in the last step to make the imaging agents selective for cancer tissue.  By use of a modular method multi-modal agents are available for targeted NIR-NMR imaging, for example.  One of our methods of evaluation is confocal fluorescence microscopy (CFM) in which cancer cells can be shown to specifically “light up” with our TMIAs.    Hans Schmitthenner

Back To Top